Evidence map›Paper›PMID 27648151›Full record

ArticleAmerican journal of translational research2016

BATF inhibition prevent acute allograft rejection after cardiac transplantation.

Bo Yang, Fan He, Chen Dai, Rumeng Tan, Dongxia Ma, Zhimin Wang, Bo Zhang, Jincheng Feng, Lai Wei, Hua Zhu and 1 more

Abstract read
In one paragraph

Article in American journal of translational research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Genetically targeting the BATF family transcription factors BATF and BATF3 in the mouse abrogates effector T cell activities and enables long-term heart allograft survival.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bo YangInstitute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Key Laboratory of Ministry of Health and Key Laboratory of Ministry of EducationWuhan, China.
Fan HeDepartment of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, China.
Chen DaiInstitute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Key Laboratory of Ministry of Health and Key Laboratory of Ministry of EducationWuhan, China.
Rumeng TanInstitute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Key Laboratory of Ministry of Health and Key Laboratory of Ministry of EducationWuhan, China.
Dongxia MaInstitute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Key Laboratory of Ministry of Health and Key Laboratory of Ministry of EducationWuhan, China.
Zhimin WangInstitute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Key Laboratory of Ministry of Health and Key Laboratory of Ministry of EducationWuhan, China.
Bo ZhangInstitute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Key Laboratory of Ministry of Health and Key Laboratory of Ministry of EducationWuhan, China.
Jincheng FengInstitute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Key Laboratory of Ministry of Health and Key Laboratory of Ministry of EducationWuhan, China.
Lai WeiInstitute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Key Laboratory of Ministry of Health and Key Laboratory of Ministry of EducationWuhan, China.
Hua ZhuDepartment of Surgery, Davis Heart and Lung Research Institute, The Ohio State University Columbus, Ohio, United States of America.
Zhishui ChenInstitute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, China; Key Laboratory of Ministry of Health and Key Laboratory of Ministry of EducationWuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute allograft rejection is a serious and life-threatening complication of organ transplantation. Th17 cells induced inflammation has been described to play an important role in allograft rejection. Since there is a plenty of evidence indicating that transcriptional factor BATF regulates the differentiation of Th17 and follicular T helper cells both in vitro and in vivo, we investigated whether is BATF involved in acute rejection and allograft survival by injecting lentivirus containing BATF shRNA through tail vein before the cardiac transplantation operation. We found that the allograft survival time of the mice treated with BATF shRNA was significantly prolonged compared with that of negative shRNA treated group and the control group. Further pathological analysis revealed that the BATF shRNA treatment group had significantly lower rejection degree than the negative shRNA group, while there was no significant difference between the negative shRNA group and the control group. Furthermore, flow cytometry analysis and quantitative polymerase chain reaction and enzyme-linked immuno sorbent assay were used to determine the proportion of T helper cells, the expression of specific transcription factor and the inflammatory cytokines respectively. Data showed that BATF regulated Th17 and Treg responses during allograft rejection. And BATF inhibition led to reduction of the expression level of Rorγ-t and enhancement of the Foxp-3. In addition, cytokines IL-17A and IL-4 were found decreased. This may indicate BATF as a novel therapy target for treatment of acute allograft rejection.

Indexed as

Acute allograft rejectionBATFheterotopic cardiac transplantationlentiviral vectorsshRNATh17

Identifiers

PMID27648151
PMCPMC5009413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.